In two syngeneic breast cancer tumor models, it was demonstrated that tumors were less vascularized and more hypoxic and anti-VEGF therapy was less potent in reducing vessel density in obese, compared to lean mice. The gene discussed is VEGFA; the disease is breast carcinoma.